Technical Analysis for XLRN - Acceleron Pharma Inc.

Grade Last Price % Change Price Change
grade C 42.06 1.18% 0.49
XLRN closed up 1.18 percent on Friday, May 24, 2019, on 74 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Flat
See historical XLRN trend table...

Date Alert Name Type % Chg
Bollinger Band Squeeze Range Contraction 0.00%
Upper Bollinger Band Walk Strength 0.00%
Inside Day Range Contraction 0.00%
50 DMA Resistance Bearish 1.18%
180 Bearish Setup Bearish Swing Setup 1.18%
Expansion Pivot Sell Setup Bearish Swing Setup 1.18%
20 DMA Support Bullish 1.18%
Bollinger Band Squeeze Range Contraction 1.18%
Stochastic Reached Overbought Strength 1.18%
Upper Bollinger Band Walk Strength 1.18%

Older signals for XLRN ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Acceleron Pharma Inc., a clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of protein therapeutics for cancer and rare diseases. The company develops sotatercept and ACE-536 that are in Phase II clinical trials to treat anemia and associated complications in patients with ß-thalassemia and myelodysplastic syndromes (MDS), and red blood cell disorders; and dalantercept, which is in Phase II clinical trials to inhibit blood vessel formation in tumors through the vascular endothelial growth factor pathway inhibitors. It has collaboration, license, and option agreement with Celgene Corporation. The company, formerly known as Phoenix Pharma, Inc., was founded in 2003 and is headquartered in Cambridge, Massachusetts.
Biotechnology Cancer Life Sciences Rare Diseases Tumors Anemia Celgene Myelodysplastic Syndrome Myelodysplastic Syndromes Therapeutics For Cancer Ace 536
Is XLRN a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 2 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 59.59
52 Week Low 32.53
Average Volume 295,138
200-Day Moving Average 46.9607
50-Day Moving Average 43.1366
20-Day Moving Average 41.4755
10-Day Moving Average 41.928
Average True Range 1.5135
ADX 17.04
+DI 17.7472
-DI 14.7501
Chandelier Exit (Long, 3 ATRs ) 38.8195
Chandelier Exit (Short, 3 ATRs ) 44.0405
Upper Bollinger Band 43.0651
Lower Bollinger Band 39.8859
Percent B (%b) 0.68
BandWidth 7.665248
MACD Line -0.0994
MACD Signal Line -0.3159
MACD Histogram 0.2165
Fundamentals Value
Market Cap 1.62 Billion
Num Shares 38.6 Million
EPS -2.49
Price-to-Earnings (P/E) Ratio -16.89
Price-to-Sales 108.28
Price-to-Book 7.53
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 43.61
Resistance 3 (R3) 43.63 43.13 43.35
Resistance 2 (R2) 43.13 42.74 43.12 43.27
Resistance 1 (R1) 42.60 42.49 42.87 42.58 43.18
Pivot Point 42.10 42.10 42.23 42.09 42.10
Support 1 (S1) 41.56 41.70 41.83 41.54 40.94
Support 2 (S2) 41.06 41.46 41.05 40.85
Support 3 (S3) 40.53 41.06 40.77
Support 4 (S4) 40.51